Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
05/11/2026
According to the Wall Street Journal: AstraZeneca (AZN.O) has made a $10 billion acquisition offer for Rhythm Pharmaceuticals, according to people familiar with the matter.
Latest
14 m ago
Brazilian Central Bank: The labor market is showing signs of slowing at the margin.
14 m ago
Microsoft (MSFT.O) completed a $25 billion bond issuance on November 4, divided into 10 tranches, including $2 billion in floating-rate notes and $23 billion in fixed-rate notes, with maturities ranging from 2028 to 2066, and fixed-rate notes carrying coupon rates of 4.85% to 6.35%. Underwriters include JPMorgan, UBS and Wells Fargo.
15 m ago
Brazilian Central Bank: The upside and downside risks to inflation remain above normal levels, with an upward asymmetry.
19 m ago
Brazilian Central Bank: The committee will monitor fiscal policy developments.
20 m ago
Earnings report shows Arm (ARM.O) FY2026 Q2 revenue of $1.44 billion, up 27% year-over-year, beating market expectations of $1.38 billion; adjusted EPS of $0.52, above expectations of $0.47. The company expects Q3 revenue of approximately $1.54 billion, broadly in line with market expectations of $1.53 billion. Data center business growth offset weakness in the smartphone market, and Arm is transitioning from a chip architecture licensor to a chip manufacturer, with its in-house CPUs expected to contribute up to $2 billion in combined revenue in fiscal 2027 and fiscal 2028. CEO Haas said the company is more confident in achieving this revenue target, but supply capacity is still constraining growth. Q2 licensing revenue grew 50% year-over-year to $773 million, while royalty revenue rose 8% to $670 million. Following the earnings release, Arm's after-hours stock fluctuated, having previously risen more than 4% and now down 3.8%.
See all latest